This randomized multicenter pilot trial assesses feasibility of the THRIVE Wellness Program, a 6-week lifestyle intervention for young breast cancer survivors aged 40 years or younger.
Marleen Meyers, MD
Advertisement
Articles by Marleen Meyers, MD
Cancer Network spoke with Marleen Meyers, MD, about evidence on low-dose tamoxifen vs placebo in women who had surgery for their ductal carcinoma in situ.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Debating CAR T-Cell Therapy Vs Bispecifics at First Relapse in Myeloma
2
Perioperative Durvalumab Combo Boosts Survival in Resectable Gastric Cancer
3
Which Lung Cancer Presentations Will Move the Needle at WCLC 2026?
4
Neoadjuvant Atezolizumab Does Not Significantly Improve EFS in Early TNBC
5